SPOTLIGHT -
EP. 1: Colorectal Cancer Screening and Prevention
EP. 2: Molecular Testing in Colorectal Cancer
EP. 3: Adjuvant Therapy in Stage II Colon Cancer
EP. 4: Exercise and Lifestyle Factors in Patients with mCRC
EP. 5: Expanded RAS Testing Required in CRC
EP. 6: Communication Strategies for Newly Diagnosed mCRC
EP. 7: Treatment Selection in RAS Wild-Type mCRC
EP. 8: Postoperative Therapy for Metastatic CRC
EP. 9: Second-Line Therapy for Metastatic CRC
EP. 10: Third-Line Regorafenib and TAS-102 in mCRC
EP. 11: Measuring Therapeutic Response in Colon Cancer
EP. 12: Molecular Profiling in Colorectal Cancer
EP. 13: Impact of Vitamin D on Colorectal Cancer Outcomes
EP. 14: Final Thoughts on Improving Outcomes in CRC
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
